跳转至内容
Merck
CN
  • CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.

Nature communications (2021-04-25)
Mitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, Branden A Smeester, Xiaohong Qiu, Nicholas J Slipek, Patricia N Claudio Vázquez, Samuel P Pitzen, Emily J Pomeroy, Madison J Vignes, Samantha C Lee, Samuel P Bingea, Aneesha A Andrew, Beau R Webber, Branden S Moriarity
摘要

CRISPR-Cas9 cytidine and adenosine base editors (CBEs and ABEs) can disrupt genes without introducing double-stranded breaks by inactivating splice sites (BE-splice) or by introducing premature stop (pmSTOP) codons. However, no in-depth comparison of these methods or a modular tool for designing BE-splice sgRNAs exists. To address these needs, we develop SpliceR ( http://z.umn.edu/spliceR ) to design and rank BE-splice sgRNAs for any Ensembl annotated genome, and compared disruption approaches in T cells using a screen against the TCR-CD3 MHC Class I immune synapse. Among the targeted genes, we find that targeting splice-donors is the most reliable disruption method, followed by targeting splice-acceptors, and introducing pmSTOPs. Further, the CBE BE4 is more effective for disruption than the ABE ABE7.10, however this disparity is eliminated by employing ABE8e. Collectively, we demonstrate a robust method for gene disruption, accompanied by a modular design tool that is of use to basic and translational researchers alike.

材料
产品编号
品牌
产品描述

Roche
不含EDTA的cOmplete蛋白酶抑制剂混合物, Tablets provided in glass vials
Sigma-Aldrich
磷酸酶抑制剂混合物3, DMSO solution
Sigma-Aldrich
磷酸酶抑制剂混合物2, aqueous solution (dark coloration may develop upon storage, which does not affect the activity)